Mark de Belder
-
- Acute Myocardial Infarction Research 107
- Cardiac Valve Diseases and Treatments 35
- Atrial Fibrillation Management and Outcomes 19
- Internal Medicine top 0.5%
-
- Cardiac Imaging and Diagnostics 48
-
- Vascular Procedures and Complications 29
- Surgery top 1%
- Coronary Interventions and Diagnostics 68
-
- Infective Endocarditis Diagnosis and Management 20
-
- COVID-19 and healthcare impacts 18
- Co-authors
- Mamas A. MamasPeter LudmanChun Shing KwokChris P GaleA. John CammJohn DeanfieldJames NolanTim Kinnaird
- Cited by
- Cardiology and Cardiovascular MedicineInternal MedicineRadiology, Nuclear Medicine and Imaging
- Journals
- Heart (41 papers)JACC: Cardiovascular Interventions (18 papers)Circulation Cardiovascular Interventions (14 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Mark de Belder
231 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Cardiology and Cardiovascular Medicine 4.3k
- Internal Medicine 536
- Radiology, Nuclear Medicine and Imaging 1.2k
- Pulmonary and Respiratory Medicine 1.6k
- Surgery 2.1k
Countries citing papers authored by Mark de Belder
This map shows the geographic impact of Mark de Belder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark de Belder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark de Belder more than expected).
Fields of papers citing papers by Mark de Belder
This network shows the impact of papers produced by Mark de Belder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark de Belder. The network helps show where Mark de Belder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark de Belder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 39 | |
| 7 | 2021 | 26 | |
| 8 | 2021 | 43 | |
| 9 | 2021 | 16 | |
| 10 | 2020 | 77 | |
| 11 | 2020 | 68 | |
| 12 | 2020 | 59 | |
| 13 | 2020 | 117 | |
| 14 | 2020 | 49 | |
| 15 | 2020 | 4 | |
| 16 | 2019 | 7 | |
| 17 | 2019 | 20 | |
| 18 | 2015 | 214 | |
| 19 | 2012 | 55 | |
| 20 | Epidemiological characteristics of cutaneous American leishmaniasis in an endemic region of the State of Bahia, Brazil. I. Human leishmaniasis. | 1981 | 10 |
About Mark de Belder
Mark de Belder is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Radiology, Nuclear Medicine and Imaging, having authored 241 papers that have together received 6.4k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (107 papers), Coronary Interventions and Diagnostics (68 papers), Cardiac Imaging and Diagnostics (48 papers), Cardiac Valve Diseases and Treatments (35 papers), Vascular Procedures and Complications (29 papers), Infective Endocarditis Diagnosis and Management (20 papers), Atrial Fibrillation Management and Outcomes (19 papers) and COVID-19 and healthcare impacts (18 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (4.3k citations), Internal Medicine (536 citations) and Radiology, Nuclear Medicine and Imaging (1.2k citations). Mark de Belder has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Mamas A. Mamas, Peter Ludman, Chun Shing Kwok, Chris P Gale, A. John Camm, John Deanfield, James Nolan, Tim Kinnaird, G Leech and Evangelos Kontopantelis. Their work appears in journals such as Heart, JACC: Cardiovascular Interventions, Circulation Cardiovascular Interventions, Catheterization and Cardiovascular Interventions and American Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.